Relapsed/Refractory Poorly Differentiated Thyroid Cancer
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Poorly Differentiated Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer (NCT04420754) | AffyImmune Therapeutics, Inc. | 2020-09-28 |
Track Relapsed/Refractory Poorly Differentiated Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.